Insulin-like growth factor-I prevents development of a vincristine neuropathy in mice

Brain Research

Volumn 774, Issue 1-2, 1997, Pages 20-26

  Contreras, Patricia C ^a   Vaught, Jeffry L ^a   Gruner, John A ^a   Brosnan, Celia ^b   Steffler, Cathy ^a   Arezzo, Joseph C ^b   Lewis, Michael E ^a,c   Kessler, John A ^b   Apfel, Stuart C ^b  

^a CEPHALON INC   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c Biodiligence Partners Inc   (United States)

Author keywords

Insulin like growth factor I; Neuropathy; Neurotrophic; Vincristine

Indexed keywords

SOMATOMEDIN C; VINCRISTINE;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DEMYELINATION; GAIT; HOT PLATE TEST; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTONEURON; MOUSE; NERVE CONDUCTION; NEUROTOXICITY; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; SCIATIC NERVE; SENSORIMOTOR NEUROPATHY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031558628     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)81682-4     Document Type: Article

References (39)

1. Andersson I.K., Edwall G., Norstedt G., Rozell B., Skottner A., Hansson H.-A. Differing expression of insulin like growth factor I in the developing and in the adult rat cerebellum. Acta Physiol. Scand. 132:1988;167-173.
2. Ang L.C., Bhaumick B., Munoz D.G., Sass J., Juurlink B.H.J. Effects of astrocytes, insulin and insulin like growth factor I on the survival of motoneurons in vitro. J. Neurol. Sci. 109:1992;168-172.
3. Apfel S.C., Lipton R.B., Arezzo J.C., Kessler J.A. Nerve growth factor prevents toxic neuropathy in mice. Ann. Neurol. 29:1991;87-90.
4. Apfel S.C., Arezzo J.C., Lipson L., Kessler J.A. Nerve growth factor prevents experimental cisplatin neuropathy. Ann. Neurol. 31:1992;76-80.
5. Apfel S.C., Arezzo J.C., Lewis M.E., Kessler J.A. The use of insulin-like growth factor I in the prevention of vincristine neuropathy in mice. Ann. NY Acad. Sci. 692:1993;243-245.
6. Apfel S.C., Arezzo J.C., Brownlee M., Federhoff J., Kessler J.A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res. 634:1994;7-12.
7. Bondy C.A., Werner H., Roberts C.T. Jr., LeRoith D. Cellular pattern of type I insulin like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin like growth factors I and II. Neuroscience. 46:1992;904-923.
8. Bradley W.G. The neuromyopathy of vincristine in the guinea pig: an electrophysiological and pathological study. J. Neurol. Sci. 10:1970;133-162.
9. C. Brody, E. Chin, IGF-I mRNA localization in trigeminal and sympathetic nerve target zones during rat embryonic development, in: M.K. Raizada, D. LeRoith (Eds.), Molecular Biology and Physiology of Insulin and Insulin Like Growth Factors, Plenum, New York, 1991, pp. 431-437.
10. Caccia M.R., Comotti B., Ubiali E., Lucchetti A. Vincristine polyneuropathy in man: A clinical and electrophysiological study. J. Neurol. 216:1977;21-26.
11. Caroni P., Grandes P. Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin like growth factors. J. Cell. Biol. 110:1990;1307-1317.
12. Caroni P. Activity-sensitive signaling by muscle-derived insulin-like growth factors in the developing and regenerating neuromuscular system. Ann. NY Acad. Sci. 692:1993;209-222.
13. Contreras P.C., Steffler C., Yu E., Callison K., Stong D., Vaught J.L. Systemic administration of rhIGF-I enhanced regeneration after sciatic nerve crush in mice. J. Pharmacol. Exp. Ther. 274:1995;1443-1449.
14. D'Amour F.E., Smith D.L. A method for determining loss of pain sensation. J. Pharmacol. Exp. Ther. 72:1941;74-79.
15. Daughaday W.H., Rotwein P. Insulin like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Mol. Endocrinol. 10:1989;68-91.
16. de Medinaceli L., Freed W.J., Wyat R.J. An index of the functional condition of the rat sciatic nerve based on measurements made from walking tracks. Exp. Neurol. 77:1982;634-643.
17. Di Gregorio F., Favaro G., Panozzo C., Fiori M.G. Efficacy of ganglioside treatment in reducing functional alterations induced by vincristine in rabbit peripheral nerves. Cancer Chemother. Pharmacol. 26:1990;31-36.
18. Eddy N.B., Leimbach D. Synthetic analgesic (II): dithienybutenyl and dithienylbutylamines. J. Pharmacol. Exp. Ther. 107:1953;385-389.
19. Edwall D., Schalling M., Jennische E., Norstedt G. Induction of insulin like growth factor I messenger ribonucleic acid during regeneration of rat skeletal muscle. Endocrinology. 124:1989;820-825.
20. Ewton D.Z., Florini J.R. Effects of insulin like growth factors and transforming growth factor b on the growth and differentiation of muscle cells in culture. Proc. Soc. Exp. Biol. Med. 194:1990;76-80.
21. Favaro G., DiGregorio F., Panozzo C., Fiori M.G. Ganglioside treatment of vincristine-induced neuropathy. An electrophysiologic study. Toxicology. 49:1988;325-329.
22. Fernyhough P., Mill J.F., Roberts J.L., Ishii D.N. Stabilization of tubulin mRNAs by insulin and insulin-like growth factor I during neurite formation. Mol. Brain Res. 6:1989;109-120.
23. Fernyhough P., Willars G.B., Lindsay R.M., Tomlinson D.R. Insulin and insulin like growth factor I enhance regeneration in cultured adult rat sensory neurons. Brain Res. 607:1993;117-124.
24. Florini J.R., Ewton D.Z., Magri K.A., Mangiacapra F.J. IGFs and muscle differentiation. Adv. Exp. Med. Biol. 343:1993;319-326.
25. Garcia-Segura L.M., Perez J., Pons S., Rejas M.T., Torres-Aleman I. Localization of insulin like growth factor I (IGF-I) like immunoreactivity in the developing and adult rat brain. Brain Res. 560:1991;167-174.
26. Hare G.M.R., Evans P.J., Mackinnon S.E., Best T.J., Bain J.R., Szalai J.P., Hunter D.A. Walking track analysis: A long-term assessment of peripheral nerve recovery. Plast. Reconstruct. Surg. 89:1992;251-258.
27. Jennische E., Skottner A., Hansson H.A. Satellite cells express the trophic factor IGF-I in regenerating skeletal muscle. Acta Physiol. Scand. 129:1987;9-15.
28. Kanje M., Skottner A., Sjorberg J., Lundborg G. Insulin like growth factor I (IGF-I) stimulates regeneration of the rat sciatic nerve. Brain Res. 486:1989;396-398.
29. LeRoith D., Adamo M.L., Werner H., Roberts Jr C.T. Insulin like growth factors and their receptors as growth regulators in normal physiology and in pathological states. Trends Endocrinol. Metab. 134:1991;134-139.
30. Lewis M.E., Neff N.T., Contreras P.C., Stong D.B., Grebow P.E., Vaught J.L. Insulin like growth factor-I: Potential for treatment of motor neuronal disorders. Exp. Neurol. 124:1993;73-88.
31. Near S.L., Whalen L.R., Miller J.A., Ishii D.N. Insulin like growth factor II stimulates motor nerve regeneration. Proc. Natl. Acad. Sci. USA. 89:1992;11716-11720.
32. Neff N.T., Prevette D., Houenou L.J., Lewis M.E., Glicksman M.A., Yin Q.-W., Oppenheim R.W. Insulin-like growth factors: putative muscle-derived trophic agents that promote motoneuron survival. J. Neurobiol. 24:1993;1578-1588.
33. Rosenthal S., Kaufman S. Vincristine neurotoxicity. Ann. Intern. Med. 80:1974;733-737.
34. Shiraishi S., Le Quesne P.M., Gajree T. The effect of vincristine on nerve regeneration in the rat. An electrophysiological study. J. Neurol. Sci. 71:1985;9-17.
35. Sjöberg J., Kanje M. Insulin like growth factor-I (IGF-I) as a stimulator of regeneration in the freeze injured rat sciatic nerve. Brain Res. 485:1989;102-108.
36. Slotwiner P., Song S.K., Anderson P.J. Spheromembranous degeneration of muscle induced by vincristine. Arch. Neurol. 15:1966;172-176.
37. Stong D.B., Wenk M.L., Contreras P.C. Effects of insulin-like growth factor-I on the neurotoxicity and efficacy of antineoplastic agents. Proc. Am. Assoc. Cancer Res. 35:1994;323.
38. J.L. Vaught, P.C. Contreras, M.A. Glicksman, N.T. Neff, Potential utility of rhIGF-I in neuromuscular and/or degenerative disease, in: G.R. Bock, J.A. Goode (Eds.), Growth Factors as Drugs for Neurological and Sensory Disorders, Ciba Foundation Symposium, John Wiley and Sons, 1996, pp. 18-27.
39. Vergara J., Medina L., Maulen J., Inestrosa N.C., Alvarez J. Nerve regeneration is improved by insulin like growth factor-I (IGF-I) and basic fibroblast growth factor (bFGF). Restor. Neurol. Neurosci. 5:1993;181-189.